Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5206602
Max Phase: Preclinical
Molecular Formula: C25H33N3O2S
Molecular Weight: 439.63
Associated Items:
ID: ALA5206602
Max Phase: Preclinical
Molecular Formula: C25H33N3O2S
Molecular Weight: 439.63
Associated Items:
Canonical SMILES: CN1C=C2C[C@@H]3[C@H](C[C@@H](CNS(=O)(=O)CCc4ccccc4)CN3C)C3C=CC=C1C23
Standard InChI: InChI=1S/C25H33N3O2S/c1-27-16-19(15-26-31(29,30)12-11-18-7-4-3-5-8-18)13-22-21-9-6-10-23-25(21)20(14-24(22)27)17-28(23)2/h3-10,17,19,21-22,24-26H,11-16H2,1-2H3/t19-,21?,22+,24+,25?/m0/s1
Standard InChI Key: HOJTZWIHQHBEEQ-MODIBDHSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 439.63 | Molecular Weight (Monoisotopic): 439.2293 | AlogP: 3.00 | #Rotatable Bonds: 6 |
Polar Surface Area: 52.65 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.81 | CX Basic pKa: 9.44 | CX LogP: 1.50 | CX LogD: -0.98 |
Aromatic Rings: 1 | Heavy Atoms: 31 | QED Weighted: 0.74 | Np Likeness Score: 0.31 |
1. Johnson JW, Ellis MJ, Piquette ZA, MacNair C, Carfrae L, Bhando T, Ritchie NE, Saliba P, Brown ED, Magolan J.. (2022) Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic Discovery., 13 (2.0): [PMID:35178184] [10.1021/acsmedchemlett.1c00648] |
Source(1):